STOCKNO.DE
Institutional ownership intelligence
Schedule 13G

APLSUSD Schedule 13G filing by State Street

State Street reported beneficial ownership of 6.8M shares, representing 12% of APELLIS PHARMACEUTICALS INC in this filing.

FiledMay 12, 2026
Ownership dateMar 31, 2026
Reported shares6.8M
Reported ownership12%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 6.6M
Shared voting power 6.6M
Sole dispositive power 6.8M
Shared dispositive power 6.8M
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
State Street
CIK
CIK0000093751
Accession
0000093751-26-000206
Form
Schedule 13G
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.